drugset / Trial / NCT00073476

A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

NCT00073476 ↗

Phase 2 Terminated 300 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.

Timeline

Start
2003-09
Primary completion
—
Completion
2005-02

Drugs

EvaluationDrugModalityDoseRoute
Subject traxiprodil Unknown — —

Indications